Literature DB >> 20566921

Treatment of recalcitrant generalized morphea with infliximab.

Mohammad Diab1, Jacquelyn R Coloe, Cynthia Magro, Mark A Bechtel.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20566921     DOI: 10.1001/archdermatol.2010.120

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  8 in total

Review 1.  [Off-label use of infliximab].

Authors:  M Onder; C Salavastru; K Fritz
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

2.  Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Authors:  Kathryn S Torok; Katherine Kurzinski; Christina Kelsey; Jonathan Yabes; Kelsey Magee; Abbe N Vallejo; Thomas Medsger; Carol A Feghali-Bostwick
Journal:  Semin Arthritis Rheum       Date:  2015-06-17       Impact factor: 5.532

Review 3.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

4.  A Case Report of Successful Treatment of Recalcitrant Childhood Localized Scleroderma with Infliximab and Leflunomide.

Authors:  Ian D Ferguson; Peter Weiser; Kathryn S Torok
Journal:  Open Rheumatol J       Date:  2015-06-26

Review 5.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

6.  Localized cutaneous sclerodermoid changes secondary to human cytomegalovirus infection: An uncommon presentation in an immunocompetent host.

Authors:  Seth Bernstein; Thomas Meskey; Klaus Helm; Jeffrey Miller; Galen Foulke; Catherine Chung
Journal:  JAAD Case Rep       Date:  2016-03-04

Review 7.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

8.  Current treatment strategies: collagen vascular diseases in children.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.